Literature DB >> 21742675

FoxO3 hastens autophagy and shrinks the heart but does not curtail pathological hypertrophy in adult mice.

Xuejun Wang, Huabo Su.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21742675      PMCID: PMC3156910          DOI: 10.1093/cvr/cvr196

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  15 in total

1.  Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B.

Authors:  H Takaishi; H Konishi; H Matsuzaki; Y Ono; Y Shirai; N Saito; T Kitamura; W Ogawa; M Kasuga; U Kikkawa; Y Nishizuka
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

2.  FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.

Authors:  Ji-Hye Paik; Ramya Kollipara; Gerald Chu; Hongkai Ji; Yonghong Xiao; Zhihu Ding; Lili Miao; Zuzana Tothova; James W Horner; Daniel R Carrasco; Shan Jiang; D Gary Gilliland; Lynda Chin; Wing H Wong; Diego H Castrillon; Ronald A DePinho
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

Review 3.  Forkhead transcription factors and cardiovascular biology.

Authors:  Kyriakos N Papanicolaou; Yasuhiro Izumiya; Kenneth Walsh
Journal:  Circ Res       Date:  2008-01-04       Impact factor: 17.367

4.  Autophagy and p62 in cardiac proteinopathy.

Authors:  Qingwen Zheng; Huabo Su; Mark J Ranek; Xuejun Wang
Journal:  Circ Res       Date:  2011-06-09       Impact factor: 17.367

5.  FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model.

Authors:  Tobias G Schips; Astrid Wietelmann; Katharina Höhn; Silvia Schimanski; Paul Walther; Thomas Braun; Thomas Wirth; Harald J Maier
Journal:  Cardiovasc Res       Date:  2011-05-30       Impact factor: 10.787

6.  The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling.

Authors:  Carsten Skurk; Yasuhiro Izumiya; Henrike Maatz; Peter Razeghi; Ichiro Shiojima; Marco Sandri; Kaori Sato; Ling Zeng; Stephan Schiekofer; David Pimentel; Stewart Lecker; Heinrich Taegtmeyer; Alfred L Goldberg; Kenneth Walsh
Journal:  J Biol Chem       Date:  2005-03-21       Impact factor: 5.157

7.  Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling.

Authors:  Yan G Ni; Kambeez Berenji; Na Wang; Misook Oh; Nita Sachan; Asim Dey; Jun Cheng; Guangrong Lu; David J Morris; Diego H Castrillon; Robert D Gerard; Beverly A Rothermel; Joseph A Hill
Journal:  Circulation       Date:  2006-09-04       Impact factor: 29.690

8.  FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases.

Authors:  Yan G Ni; Na Wang; Dian J Cao; Nita Sachan; David J Morris; Robert D Gerard; Makoto Kuro-O; Beverly A Rothermel; Joseph A Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-12       Impact factor: 11.205

9.  Shear stress-induced activation of the AMP-activated protein kinase regulates FoxO1a and angiopoietin-2 in endothelial cells.

Authors:  Madhulika Dixit; Elke Bess; Beate Fisslthaler; Frauke V Härtel; Thomas Noll; Rudi Busse; Ingrid Fleming
Journal:  Cardiovasc Res       Date:  2007-09-19       Impact factor: 10.787

10.  Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.

Authors:  Hui-Hua Li; Monte S Willis; Pamela Lockyer; Nathaniel Miller; Holly McDonough; David J Glass; Cam Patterson
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

View more
  2 in total

1.  The autophagy-related gene 14 (Atg14) is regulated by forkhead box O transcription factors and circadian rhythms and plays a critical role in hepatic autophagy and lipid metabolism.

Authors:  Xiwen Xiong; Rongya Tao; Ronald A DePinho; X Charlie Dong
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

2.  Effects of Sirt3‑autophagy and resveratrol activation on myocardial hypertrophy and energy metabolism.

Authors:  Hai-Ning Wang; Ji-Lin Li; Tan Xu; Huai-Qi Yao; Gui-Hua Chen; Jing Hu
Journal:  Mol Med Rep       Date:  2020-05-28       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.